Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.470
+0.380 (18.18%)
At close: Dec 12, 2025, 4:00 PM EST
2.400
-0.070 (-2.83%)
After-hours: Dec 12, 2025, 7:56 PM EST
Daré Bioscience Market Cap
Daré Bioscience has a market cap or net worth of $35.29 million as of December 12, 2025. Its market cap has increased by 27.42% in one year.
Market Cap
35.29M
Enterprise Value
15.15M
1-Year Change
27.42%
Ranking
Category
Stock Price
$2.47
Market Cap Chart
Since April 10, 2014, Daré Bioscience's market cap has decreased from $98.00M to $35.29M, a decrease of -63.99%. That is a compound annual growth rate of -8.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 35.30M | 30.26% |
| Dec 31, 2024 | 27.10M | -11.15% |
| Dec 29, 2023 | 30.50M | -56.68% |
| Dec 30, 2022 | 70.40M | -54.05% |
| Dec 31, 2021 | 153.20M | 200.98% |
| Dec 31, 2020 | 50.90M | 271.53% |
| Dec 31, 2019 | 13.70M | 69.14% |
| Dec 31, 2018 | 8.10M | -38.17% |
| Dec 29, 2017 | 13.10M | -32.47% |
| Dec 30, 2016 | 19.40M | -74.67% |
| Dec 31, 2015 | 76.60M | -38.82% |
| Dec 31, 2014 | 125.20M | 27.76% |
| Apr 10, 2014 | 98.00M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |